These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1530670)

  • 21. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
    Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
    Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical toxicology studies with the new dopamine agonist pergolide. Acute, subchronic, and chronic evaluations.
    Francis PC; Carlson KH; Owen NV; Adams ER
    Arzneimittelforschung; 1994 Mar; 44(3):278-84. PubMed ID: 8192691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
    Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of prolonged administration of delta 9-tetrahydrocannabinol on the autonomic and cardiovascular function and regional hemodynamics in mongrel dogs.
    Jandhyala BS
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):489-508. PubMed ID: 674828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory activity of pergolide, a dopamine receptor agonist.
    Bendele AM; Spaethe SM; Benslay DN; Bryant HU
    J Pharmacol Exp Ther; 1991 Oct; 259(1):169-75. PubMed ID: 1681083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics.
    Yamamoto S; Takemori E; Hasegawa Y; Kuroda K; Nakao K; Inukai T; Sakonjyo H; Nishimura T; Nishimori T
    Arzneimittelforschung; 1991 Sep; 41(9):913-23. PubMed ID: 1796919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General pharmacology of pidotimod and testing for drug interactions.
    Manzardo S; Falcone A; Pinzetta A; Ieva G; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1441-7. PubMed ID: 7857339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological activities and side effects of plafibride.
    Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    Yoshimura N; Mizuta E; Yoshida O; Kuno S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):228-33. PubMed ID: 9655864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
    Buschmann G; Kühl UG; Rohte O
    Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardiovascular and autonomic properties of N-phenylpiperazine (NPP) in several animal models.
    Cohen MR; Hinsch E; Palkoski Z; Vergona R; Urbano S; Sztokalo J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):110-9. PubMed ID: 6126578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General pharmacology of indole [2',3':3,4]pyrido[2,1-b]quinazolinium- 5,7,8,13-tetrahydro-14-methyl-5-oxo-chloride, a new anti-dementia agent.
    Park CH; Choi SH; Kim CH; Seo JH; Koo JW; Rah JC; Kim HS; Jeong SJ; Joo WS; Lee YJ; Kim YS; Kim MS; Suh YH
    Arzneimittelforschung; 2003; 53(6):393-401. PubMed ID: 12872609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General pharmacology studies on recombinant human follicle stimulating hormone.
    Biffoni M; Cantelmo A; Marcucci I; Martelli F; Suzuki H; Borrelli F; Suzuki K
    Arzneimittelforschung; 1994 Sep; 44(9):1096-102. PubMed ID: 7986251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General pharmacology of the non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Hayashi M; Kajiwara Y; Kitabatake K; Uruno T; Kubota K
    Arzneimittelforschung; 1993 Nov; 43(11):1169-74. PubMed ID: 8292059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.